Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: MOVE - A Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: This study is designed to assess the effect of QVA149 (110/50 ug q.d.) versus placebo on pulmonary function and average physical activity levels in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).


Options:
A: Arm Label: olodaterol (BI 1744) low and placebo; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) low, Drug: Placebo, Device: Respimat | Arm Label: olodaterol (BI 1744) low and low tio; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) low, Drug: low tiotropium bromide, Device: Respimat | Arm Label: olodaterol (BI 1744) low and medium tio; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) low, Drug: medium tiotropium bromide, Device: Respimat | Arm Label: olodaterol (BI 1744) low and high tio; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) low, Drug: high tiotropium bromide, Device: Respimat | Arm Label: olodaterol (BI 1744) high and placebo; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) high, Drug: Placebo, Device: Respimat | Arm Label: Olodaterol (BI 1744) high and low tio; Type: EXPERIMENTAL; Interventions: Drug: low tiotropium bromide, Drug: olodaterol (BI 1744) high, Device: Respimat | Arm Label: Olodaterol (BI 1744) high and medium tio; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) high, Drug: medium tiotropium bromide, Device: Respimat | Arm Label: Olodaterol (BI 1744) high and high tio; Type: EXPERIMENTAL; Interventions: Drug: olodaterol (BI 1744) high, Drug: high tiotropium bromide, Device: Respimat | Intervention Type: DRUG; Name: olodaterol (BI 1744) low; Assigned to Arm(s): olodaterol (BI 1744) low and high tio, olodaterol (BI 1744) low and low tio, olodaterol (BI 1744) low and medium tio, olodaterol (BI 1744) low and placebo | Intervention Type: DRUG; Name: low tiotropium bromide; Assigned to Arm(s): Olodaterol (BI 1744) high and low tio, olodaterol (BI 1744) low and low tio | Intervention Type: DRUG; Name: olodaterol (BI 1744) high; Assigned to Arm(s): Olodaterol (BI 1744) high and high tio, Olodaterol (BI 1744) high and low tio, Olodaterol (BI 1744) high and medium tio, olodaterol (BI 1744) high and placebo | Intervention Type: DRUG; Name: medium tiotropium bromide; Assigned to Arm(s): Olodaterol (BI 1744) high and medium tio, olodaterol (BI 1744) low and medium tio | Intervention Type: DRUG; Name: high tiotropium bromide; Assigned to Arm(s): Olodaterol (BI 1744) high and high tio, olodaterol (BI 1744) low and high tio | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): olodaterol (BI 1744) high and placebo, olodaterol (BI 1744) low and placebo | Intervention Type: DEVICE; Name: Respimat; Assigned to Arm(s): Olodaterol (BI 1744) high and high tio, Olodaterol (BI 1744) high and low tio, Olodaterol (BI 1744) high and medium tio, olodaterol (BI 1744) high and placebo, olodaterol (BI 1744) low and high tio, olodaterol (BI 1744) low and low tio, olodaterol (BI 1744) low and medium tio, olodaterol (BI 1744) low and placebo
B: Arm Label: GSK573719/GW642444 125/25; Type: EXPERIMENTAL; Interventions: Drug: GSK573719/GW642444 125/25 | Arm Label: GSK573719/GW642444 62.5/25; Type: EXPERIMENTAL; Interventions: Drug: GSK573719/GW642444 62.5/25 | Arm Label: GW642444; Type: EXPERIMENTAL; Interventions: Drug: GW642444 | Arm Label: tiotropium bromide; Type: ACTIVE_COMPARATOR; Interventions: Drug: tiotropium bromide | Intervention Type: DRUG; Name: GSK573719/GW642444 125/25; Assigned to Arm(s): GSK573719/GW642444 125/25 | Intervention Type: DRUG; Name: GSK573719/GW642444 62.5/25; Assigned to Arm(s): GSK573719/GW642444 62.5/25 | Intervention Type: DRUG; Name: GW642444; Assigned to Arm(s): GW642444 | Intervention Type: DRUG; Name: tiotropium bromide; Assigned to Arm(s): tiotropium bromide
C: Arm Label: Treatment sequence I; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVA149, Drug: Placebo | Arm Label: Treatment sequence II; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVA149, Drug: Placebo | Intervention Type: DRUG; Name: QVA149; Assigned to Arm(s): Treatment sequence I, Treatment sequence II | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Treatment sequence I, Treatment sequence II
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aclidinium Bromide | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol Fumarate | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aclidinium Bromide/Formoterol Fumarate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aclidinium Bromide/Formoterol Fumarate; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Aclidinium Bromide; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Formoterol Fumarate; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 5

Answer: C